You are here

Xarelto

J&J blood thinner under review for trial overseen by FDA nominee Califf

Stat

Wed, 12/9/15 - 11:44 am

How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says

Fierce Pharma

Thu, 10/1/15 - 05:29 pm

Boehringer Ingelheim

Bristol-Myers Squibb

J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data

Fierce Pharma

Tue, 09/1/15 - 06:37 pm

Bristol-Myers Squibb

Bydureon, Invokana, Xarelto brand teams shelled out most to doctors in 2014

Fierce Pharma Marketing

Wed, 07/8/15 - 11:34 am

physician payments

Bayer, J&J touting Xarelto trial data to counteract Eliquis surge

Fierce Pharma Marketing

Tue, 06/30/15 - 11:30 am

clinical trial data

Bristol-Myers Squibb

Should Eliquis' surge make Xarelto fans very, very afraid? Not really, analyst says

Fierce Pharma Marketing

Mon, 05/18/15 - 10:37 am

Bristol-Myers Squibb

Bayer says Xarelto isn't losing U.S. market share to Eliquis

Yahoo/Reuters

Thu, 04/30/15 - 11:10 am

Portola's drug reverses effect of J&J's blood thinner Xarelto

Yahoo/Reuters

Fri, 01/9/15 - 09:14 am

Portola Pharmaceuticals

J&J looks for Xarelto boost in real-world cost data

Fierce Pharma Marketing

Thu, 12/4/14 - 10:21 am

3 Drugs Critical to Johnson & Johnson's Future

Motley Fool

Tue, 10/21/14 - 09:20 am

Invega Sustenna

Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson

Motley Fool

Thu, 09/4/14 - 09:56 am

Bristol-Myers Squibb

Xarelto works in new cardioversion indication for AF

Pharmaphorum

Tue, 09/2/14 - 08:08 am

atrial fibrillation

Germany's Bayer to launch three new Xarelto trials

Yahoo/Reuters

Fri, 08/29/14 - 10:18 am

clinical trials

NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis

Fierce Pharma

Thu, 06/19/14 - 10:36 am

Bristol-Myers Squibb

Boehringer Ingelheim

Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo

The Fly on the Wall

Mon, 05/12/14 - 09:12 am

Portola Pharmaceuticals

Warfarin's Loss is Johnson & Johnson's Gain

Motley Fool

Mon, 04/21/14 - 04:20 pm

Boehringer Ingelheim

Why the FDA Still Won’t Approve J&J’s Blood Clot Medicine

Wall St Cheat Sheet

Sat, 02/15/14 - 11:12 am

Bayer says FDA rejects wider use of Xarelto drug

Yahoo/Reuters

Fri, 02/14/14 - 09:49 am

Bayer says FDA rejects wider use of Xarelto drug

Yahoo/Reuters

Fri, 02/14/14 - 09:49 am

Here's Why Big Pharma is Rooting for Portola

Motley Fool

Wed, 02/5/14 - 10:23 am

Portola Pharmaceuticals

Bristol-Myers Squibb

Pages